FDA Moves to Pull Controversial Preterm Birth Drug From the Market — Briefing data show Makena was ineffective in reducing preterm birth, improving neonatal outcomes by Amanda D'Ambrosio, Enterprise & Investigative Writer, MedPage Today October 14, 2022

https://www.medpagetoday.com/obgyn/pregnancy/101244?xid=nl_mpt_DHE_2022-10-14&eun=g649657d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%20Evening%202022-10-14&utm_term=NL_Daily_DHE_dual-gmail-definition